|
|
Post by deaner3 on Jun 23, 2017 9:42:35 GMT -5
Refills up 55% from last week and almost double 2 weeks ago.
New prescriptions up 27.5% from last wk and 45% from 2 weeks ago
I think the numbers are going to significantly trend up going forward. Yes.. some weeks won't be as impressive as week before but month over month are going to be significant growth up.
For those worried about cash flow... things like this will make it much easier to get those with money to take a chance to infuse some cash into the company. It's as close to a no brainer investment as there is in the market.
Is there still some risk? Of course.. there is with everything. But, I'd be extremely frightened to be short at this point... it isn't going any lower than this long term. But, upside? oh my...
|
|
|
|
Post by peppy on Jun 23, 2017 9:43:48 GMT -5
yes, inflection point and break out.
|
|
|
|
Post by akemp3000 on Jun 23, 2017 9:52:28 GMT -5
Seems fitting that this inflection point, if that's what it is, occurs at the same time an article comes out about Shkreli preparing for trial. We've waited a long time for both.
|
|
|
|
Post by deaner3 on Jun 23, 2017 10:03:35 GMT -5
All of the pieces of the puzzle are there. All we need is one last financial one to extend runway and this thing will soar and not look back. But, there has to be a reason for all the confidence of employees joining our team leaving their high up jobs at big companies. I don't know anything, but people don't leave positions they worked themselves up to for 15 to 20 years without having confidence the job will be there for awhile. They have to know something about our future finances. Just yesterday Tross posted on linkedin about 3 new jobs starting in August of this year... does that sound like a company running out of money? They know something but can't say it. I don't know what that is. But... something is happening so I'm confident.
|
|
|
|
Post by sportsrancho on Jun 23, 2017 10:48:13 GMT -5
It's good to wait until the inflection point to announce what will give us the runway:-)
|
|
|
|
Post by deaner3 on Jun 23, 2017 10:50:44 GMT -5
I was incorrect in my numbers above. It's the NEW scripts that's up 55% not refills, apologize. But I actually think that's better. But sorry for my incorrect info above.
|
|
|
|
Post by promann on Jun 23, 2017 10:58:06 GMT -5
It's good to wait until the inflection point to announce what will give us the runway:-) I was thinking the same thing! Give the news as a 1-2-3 punch. Where there is no question weather MNKD will succeed and we will be soaring and shorts covering will be near impossible because who in there right minds would sell. I really think this is the plan. 🙂 |
|
|
|
Post by sportsrancho on Jun 23, 2017 11:00:45 GMT -5
It's good to wait until the inflection point to announce what will give us the runway:-) I was thinking the same thing!  Give the news as a 1-2-3 punch. Where there is no question weather MNKD will succeed and we will be soaring and shorts covering will be near impossible because who in there right minds would sell.  I really think this is the plan. 🙂 So do I. ( Maybe 3 more weeks ) kaboom! |
|
|
|
Post by cretin11 on Jun 23, 2017 12:01:12 GMT -5
Refills up 55% from last week and almost double 2 weeks ago. New prescriptions up 27.5% from last wk and 45% from 2 weeks ago I think the numbers are going to significantly trend up going forward. Yes.. some weeks won't be as impressive as week before but month over month are going to be significant growth up. For those worried about cash flow... things like this will make it much easier to get those with money to take a chance to infuse some cash into the company. It's as close to a no brainer investment as there is in the market. Is there still some risk? Of course.. there is with everything. But, I'd be extremely frightened to be short at this point... it isn't going any lower than this long term. But, upside? oh my... Love your enthusiasm but calling this a "no-brainer" and saying it isn't going any lower than this, kinda hard to go along with those thoughts. There's a high percentage possibility of significant dilution on the near term horizon, that's not characteristic of a "no brainer" investment. And that would obviously mean an immediate downside, so yes it surely can go lower (those of us who've been around a while know it could mean much lower). Cash flow is still a huge concern. Today's numbers are a breath of fresh air and reason for optimism. We need several more similar weeks before we can realistically feel good about cash flow. I do agree with your very last statement: upside, yes it certainly does exist. It's just far from a sure thing or a no brainer just yet... |
|
|
|
Post by deaner3 on Jun 23, 2017 12:10:37 GMT -5
Fair enough. It's a no brainer imo long term. But with the manipulation in this thing it will always be a roller coaster. (Thanks to hit pieces by Spencer etc )
|
|
|
|
Post by traderdennis on Jun 23, 2017 12:56:28 GMT -5
Fair enough. It's a no brainer imo long term. But with the manipulation in this thing it will always be a roller coaster. (Thanks to hit pieces by Spencer etc ) Spencer is entertaining, his pieces carry very little weight. Now when Adam F writes about MNKD those are hit pieces and worth following in the market. As for inflection point, for another year's runway, 50-80 Million dollars needs to be invested into MNKD. Retail is tapped out as they would of driven the price higher today, so who is going to foot the bill? Deaner would you be able to answer that question? I don't know the exact number of shares available for a secondary, I think it is around 14 Million so the price would need to get to around $6 so MNKD can have a secondary @5 and net about 60Million. From $1.60 to $6 is a long way now, a triple in scripts to 1000+ won't triple the stock price. |
|
|
|
Post by radgray68 on Jun 23, 2017 12:57:09 GMT -5
Fair enough. It's a no brainer imo long term. But with the manipulation in this thing it will always be a roller coaster. (Thanks to hit pieces by Spencer etc ) Right on time. Old knock-em-down Spenc is earning his paycheck I see. Didn't read it but let me guess. It says something like: "yeah, THIS week is better but...........blah, blah......low money.....blah blah...it's been 3 years...blah, blah....I'm really rooting for Afrezza, BUT........blah, blah......use caution because I fear for your investment...blah, blah, blah"
how'd I do?
|
|
|
|
Post by orlon on Jun 23, 2017 13:00:42 GMT -5
All this excitement for an early morning gain of .15c/shr...now back to 07c/shr? They have to do better than this after a billion dollar investment over a ten year period with FDA approval over three years ago!
|
|
|
|
Post by hellodolly on Jun 23, 2017 13:04:08 GMT -5
Fair enough. It's a no brainer imo long term. But with the manipulation in this thing it will always be a roller coaster. (Thanks to hit pieces by Spencer etc ) Spencer is entertaining, his pieces carry very little weight. Now when Adam F writes about MNKD those are hit pieces and worth following in the market. As for inflection point, for another year's runway, 50-80 Million dollars needs to be invested into MNKD. Retail is tapped out as they would of driven the price higher today, so who is going to foot the bill? Deaner would you be able to answer that question? I don't know the exact number of shares available for a secondary, I think it is around 14 Million so the price would need to get to around $6 so MNKD can have a secondary @5 and net about 60Million. From $1.60 to $6 is a long way now, a triple in scripts to 1000+ won't triple the stock price. True, but 1000+ scripts (3X current) means we won't need 14M shares of dilution to get to 60M more in cash, too. |
|
|
|
Post by traderdennis on Jun 23, 2017 13:12:13 GMT -5
Spencer is entertaining, his pieces carry very little weight. Now when Adam F writes about MNKD those are hit pieces and worth following in the market. As for inflection point, for another year's runway, 50-80 Million dollars needs to be invested into MNKD. Retail is tapped out as they would of driven the price higher today, so who is going to foot the bill? Deaner would you be able to answer that question? I don't know the exact number of shares available for a secondary, I think it is around 14 Million so the price would need to get to around $6 so MNKD can have a secondary @5 and net about 60Million. From $1.60 to $6 is a long way now, a triple in scripts to 1000+ won't triple the stock price. True, but 1000+ scripts (3X current) means we won't need 14M shares of dilution to get to 60M more in cash, too. at 1000-1100 scripts, the price won't be at $6. Much closer to $3 and the secondary will bring in 30Million or less. |
|
